Metabolic syndrome 'heightens the risk of prostate cancer'

22 October 2012

New research has indicated that men have an increased risk of dying from prostate cancer if they suffer from metabolic syndrome.

The condition relates to a person recording a high body mass index, living with hypertension – otherwise known as high blood pressure – and suffering from raised blood sugar and/or blood lipids.

Scientists at Umea University, in Sweden, set out to uncover the effects of metabolic syndrome in the development of prostate cancer by analysing data gathered by The Metabolic Syndrome and Cancer Project.

Involving the information of 289,866 men, 6,673 of the individuals studied in the medical project were diagnosed with prostate cancer throughout a follow-up period covering 12 years. Of these, 861 of them died as a result of the disease.

Lead author Par Stattin, from the Memorial Sloan-Kettering Cancer Center in New York City, commented: "These observations suggest that cardiovascular risk factors such as overweight and hypertension are involved in stimulating the progression of prostate cancer."

Posted by Philip Briggs


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.
 

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)